Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)
Phase 1
Completed
- Conditions
- Multiple Sclerosis
- Registration Number
- NCT00695084
- Lead Sponsor
- National Multiple Sclerosis Society
- Brief Summary
This trial will evaluate whether progressive multiple sclerosis associated with hemiparesis may benefit from Constraint-Induced Movement Therapy.
- Detailed Description
Constraint-Induced Movement Therapy was developed to treat stroke hemiparesis. Due to the similarity between multiple sclerosis and stroke in terms of chronic motor deficit, this trial will attempt to determine whether multiple sclerosis may benefit similarly from Constraint-Induced Movement Therapy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
- Chronic upper extremity motor deficit due to multiple sclerosis
Exclusion Criteria
- Relapse within 3 months of planned enrollment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Improvement on the Motor Activity Log One year
- Secondary Outcome Measures
Name Time Method Improvement on the Wolf Motor Function Test Pre to post-treatment
Trial Locations
- Locations (1)
University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States
University of Alabama at Birmingham🇺🇸Birmingham, Alabama, United States